InvestorsHub Logo
Followers 14
Posts 284
Boards Moderated 1
Alias Born 02/11/2013

Re: None

Sunday, 10/09/2016 10:27:04 AM

Sunday, October 09, 2016 10:27:04 AM

Post# of 25
big money in owcp

OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!

OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines.

Multiple myeloma

NEW YORK (GBI Research) - The global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, representing a moderate Compound Annual Growth Rate (CAGR) of 4.6%, says business intelligence provider GBI Research.
link http://www.fiercepharma.com/marketing/global-multiple-myeloma-treatment-market-value-to-approach-9-billion-by-2021-says-gbi-0

Psoriasis

The psoriasis market is set to rise from $6.6 billion in 2014 to over $13.3 billion by 2024 at a compound annual growth rate of 7.3%, according to research and consulting firm GlobalData.
link https://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/psoriasis-market-will-more-than-double-to-133-billion-by-2024-as-drugs-greatly-improve

fibromyalgia

The treatment market value for fibromyalgia across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will expand from $1.8 billion in 2013 at a tepid Compound Annual Growth Rate (CAGR) of 0.72% to reach $1.9 billion by 2023, according to research and consulting firm GlobalData
link https://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/fibromyalgia-treatment-market-value-will-crawl-to-19-billion-by-2023-says-globaldata

post-traumatic stress disorder ( PTSD )

The annual cost to society of anxiety disorders is estimated to be significantly over $42.3 billion, often due to misdiagnosis and under treatment. This includes psychiatric and non-psychiatric medical treatment costs, indirect workplace costs, mortality costs, and prescription drug costs. An estimated 8% of Americans - 24.4 million people - have PTSD at any given time. That is equal to the total population of Texas.
link http://www.ptsdunited.org/ptsd-statistics-2/

Technavio's analysts forecast the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014-2019.
link http://www.prnewswire.com/news-releases/global-post-traumatic-stress-disorder-therapeutics-market-2015-2019-300109175.html

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.